This study elucidates the information content that is extracted from action-2D electronic spectroscopy (A-2DES) when the output intensity is not proportional to the number of excitations generated. Such a scenario can be realized in both fluorescence and photocurrent detection because of direct interaction like exciton-exciton annihilation or indirect effects in the signal generation or detection. By means of an intuitive probabilistic model supported by nonlinear response theory, the study concludes that in molecular assemblies the ground-state bleaching contribution can dominate the nonlinear signal and partially or completely hide the stimulated emission. In this case, the spectral effect resembles incoherent mixing, even in the absence of exciton-exciton annihilation, implying reduced information about the excited-state dynamics with an increasing number of chromophores. This finding has important implications for the selection of samples for A-2DES as well as for its interpretation.

Action-detection has expanded the scope and applicability of 2D electronic spectroscopy, while posing new challenges for the unambiguous interpretation of spectral features. In this context, identifying the origin of cross-peaks at early waiting times is not trivial, and incoherent mixing is often invoked as an unwanted contribution masking the nonlinear signal. In this work, we elaborate on the relation between the nonlinear response and the incoherent mixing contribution by analyzing the action signal in terms of one- and two-particle observables. Considering a weakly interacting molecular dimer, we show how cross-peaks at early waiting times, reflecting exciton-exciton annihilation dynamics, can be equivalently interpreted as arising from incoherent mixing. This equivalence, on the one hand, highlights the information content of spectral features related to incoherent mixing and, on the other hand, provides an efficient numerical scheme to simulate the action response of weakly interacting systems.

A new Cu-based anticancer metallodrug which targets the translocator protein is reported. [CuBr₂(TZ6)] elicits a remarkable in vitro cytotoxicity in sensitive and multidrug resistant cell lines and induces a 98% reduction of tumor mass in a murine tumor model. Target binding was studied by experimental and computational methods.